FT : Greece’s OTE faces activist push for board change

Greece’s OTE faces activist push for board change
Hedge fund seeks to improve corporate governance by proposing independent member

Amber Capital is making a fresh attempt to improve corporate governance at Greece’s largest telecoms operator OTE, in which Deutsche Telekom holds a controlling stake.

The London-based activist hedge fund will propose Alberto Horcajo, a former chief executive at Telefónica Brasil, to take over as an independent non-executive deputy chairman and board member at OTE’s annual shareholders’ meeting on Wednesday. Mr Horcajo’s candidacy is backed by Institutional Shareholder Services, a leading proxy adviser.

The move has highlighted continuing weak standards of corporate governance in Greece, where listed companies still ignore new requirements legislated in 2013 as a condition of the country’s second international bailout.

Greece’s creditors, the EU and International Monetary Fund imposed corporate governance reforms at the country’s biggest banks, but it was left to the Greek capital markets commission to ensure that other companies listed on the Athens stock exchange increased the number of independent members on their boards and appointed qualified board members to their audit committees.

The country’s poor governance record was highlighted by revelations last year that Folli Follie, a listed Greek jewellery maker, faced a cash hole of $290m after overstating profits from its Asian outlets by almost $1bn.

The commission delayed appointing an investigator for several months after the gap was exposed in a report by QCM, a US hedge fund. Folli Follie’s audit committee had not reported any accounting irregularities at their Asian operations.

OTE is the most prominent Greek company to fall short on governance. OTE’s 10-member board should include four independent directors, according to the Hellenic Corporate Governance Code, but only two are serving at present.

Deutsche Telekom, which holds a 45 per cent stake in the operator, has put forward its own candidate for deputy chairman: Eelco Blok, a former chief executive at the Dutch telecoms operator KPN. No other board members are due to be replaced.

Giuseppe di Mino, Amber Capital’s managing director, praised OTE’s Athens-based management team for their handling of “very difficult market conditions” during the country’s eight-year recession but said that corporate governance at the group was in urgent need of an overhaul.

“We see inadequate board independence and insufficient knowledge among audit committee members . . . Minority shareholders would be better represented by a deputy chairman that has not been sponsored by the controlling shareholder.”

In a letter seen by the Financial Times, Amber Capital urged Deutsche Telekom to back their candidate for deputy chairman. The letter pointed out that the incumbent had served as a board member since 2004, outstaying his legitimate term.

The letter suggested that governance improvements at OTE, the largest listed Greek company, might set an example for other companies to follow.

Amber Capital holds a 2 per cent stake in OTE. The fund is focused on investing in Europe, including southern Europe, and also holds stakes in a leading Greek bank and two listed construction companies.

At last year’s AGM, minority shareholders overwhelmingly backed Mr Horcajo for a post as an independent board member, but were overruled by controlling shareholder Deutsche Telekom.

FT Lex : Mediaset: don’t Dutch this

Mediaset: don’t Dutch this
Creating a holding company to house group interests is an attempt to clean up a muddled script

On camera, appearances count for a lot. The less forgiving lens of markets gives short shrift to cosmetic changes. One man not shy of the camera is Silvio Berlusconi. His life might make an epic film — or perhaps a comedy. Some of the companies he controls, like Mediaset of Italy, deserve lesser billing. Minority holders have made nothing from holding its shares for a decade. Announcing the creation of a Dutch holding company to house the Mediaset interests is an attempt to clean up a muddled script.

The new entity, rebranded MFE (MediaForEurope), premiered with a promise of a thrilling pan-European vision. Mediaset and its subsidiary Mediaset España will exchange shares for those in the new Netherlands-based company. Mediaset España’s minorities with 48.4 per cent will not be bought out, but will receive 2.33 shares of MFE for each of España. The deal offers no premium for the Spanish shares that have outrun those of its Italian parent for years. But loyal fans will receive extra voting stock if they hold their new shares for more than two years.

The new group should transform an unwieldy pairing of two companies. Into what, though? A holding company where the same players work on the same wonky set. There is no tax twist, either. The Italian and Spanish companies will continue to make payments to their respective countries.

Mr Berlusconi has created drama from a pedestrian scenario. Yes, a leaner structure combined with cost-cutting — “efficiencies” — of around €100m annually will boost earnings from next year. Taxed and capitalised Mediaset optimistically thinks these are worth €800m. But any savings might have been made independent of this structure. MFE has hopes to make it on the larger European stage but provided no clear vision for how.

Shareholders will get some cinema sweets for attending this show, €100m in dividends and up to €280m in share buybacks. But this hype must turn into real-life turnround story to sustain a rise in Mediaset’s market value.

>>> Pres Trump: without tariffs we would be at a competitive disadvantage; tarif

Pres Trump: without tariffs we would be at a competitive disadvantage; tariffs work because we are "the piggy bank" - CNBC call in
- China is getting decimated because companies are leaving China; China is going to have to make a deal because they have to make a deal
- If we put 25% tariffs on Mexico, all the companies would leave and move back to the US, including car companies
- Mexico has a big problem with drugs
- A lot of countries have changed their habits because they "know they are next" on tariffs threats

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • N/A.

M&A news:

  • ONCE -12.8% (Spark Therapeutics, Roche (RHHBY) receive request for additional information from FTC; tender offer extended until July 31)
  • CRM -4.8% (Tableau Software to be acquired by Salesforce (CRM) for $15.7 bln in stock)

Select metals/mining stocks trading lower:

  • DRD -4.5%, SBGL -3.7%, HMY -3.7%, AG -2.6%, GOLD -2.5%, GFI -2.4%, SAND -2.4%, AU -2.3%, GDX -2.1%, SLV -1.8%, GLD -1.1%

Other news:

  • NVAX -5.4% (provides update on pursuit of global licensure for ResVax)
  • GNCA -4.5% (files common stock offering of up to $50 mln)

Analyst comments:

  • RLGY -1.2% (downgraded to Equal-Weight from Overweight at Stephens)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:

  • UXIN +7.6%, TSM +1.8% (May revs), THO +1.4%

M&A news:

  • DATA +34% (Tableau Software to be acquired by Salesforce (CRM) for $15.7 bln in stock)
  • RTN +7.6% (Raytheon & United Technologies (UTX) announce all-stock merger of equals)
  • SFLY +6.7% (Apollo (APO) said to be in the lead to acquire Shutterfly, according to Reuters)
  • UTX +2.8% (Raytheon & United Technologies (UTX) announce all-stock merger of equals)

Select financial related names showing strength:

  • JPM +1.7%, BAC +1.3%, BBVA +1.3%, SAN +1.1%, WFC +1%

Select China related stocks trading higher:

  • MOMO +2.3%, WB +2.3%, BABA +2.1%, JD +1.9%, BIDU +1.5%, BBL +1.5%, BHP +0.9%

Other news:

  • PRVB +175.6% (presents results from National Institutes of Health-sponsored "At-Risk" Study -- single 14-day course of PRV-031 (teplizumab) significantly delayed the onset and diagnosis of clinical T1D)
  • TLRY +17% (signs non-binding Letter of Intent with largest stockholder Privateer Holdings to extend lock-up on and provide for the orderly release of the 75 mln shares)
  • EROS +12.1% (provides statement from Group Chairman and CEO Kishore Lulla, announces $20 mln share repurchase program)
  • APTX +10.6% (reports 'positive' top-line results from a 23-patient, single-blind, sequential design Phase 2 study of its novel NMDA receptor modulator, NYX-2925, in patients with fibromyalgia)
  • DOMO +10% (in sympathy with DATA)
  • HCR +9.9% (approves stock repurchase program of up to $25 mln effective immediately)
  • MNKD +9.2% (presents new data from three different studies of Afrezza Inhalation Powder at the American Diabetes Association's 79th Scientific Sessions)
  • AYX +7.2% (in sympathy with DATA)
  • LYB +5.3% (commenced a 'modified Dutch Auction' tender offer to purchase up to 37,000,000 of its issued and outstanding ordinary shares)
  • KHC +3% (files Annual Report on Form 10-K)
  • CRK +2.7% (to acquire Covey Park Energy in a cash and stock transaction valued at approximately $2.2 bln)
  • ECA +2.6% (provides corporate update, will execute substantial issuer bid to fulfill its previously announced 2019 share buyback)
  • WDAY +2.3% (in sympathy with DATA)
  • NOW +2.3% (in sympathy with DATA)
  • NVO +2.2% (presents two phase 3a clinical trials evaluated oral semaglutide 14 mg vs Jardiance; demonstrated statistically significant blood sugar reductions) GM +1.7% (following suspension of Mex tariffs)
  • KSU +1.7% (following suspension of Mex tariffs)
  • F +1.4% (following suspension of Mex tariffs)

Analyst comments:

  • RDFN +6.8% (upgraded to Overweight from Underweight at Stephens)
  • AMD +4.5% (target raised to $40 from $35 at BofA/Merrill ahead of the company's appearance at E3 this week)
  • MDGL +3% (pgraded to Buy at B. Riley FBR)
  • ETON +2.6% (initiated with a Buy at H.C. Wainwright)
  • ADI +2.4% (upgraded to Buy from Sell at Goldman)
  • FII +0.9% (upgraded to Overweight from Neutral at JP Morgan)

>>> US Early premarket gappers

Early premarket gappers

Gapping up:

  • MNKD +20.2%, RTN +9.5%, GRPN +5.1%, CVA +4.4%, UTX +3.9%, STZ +3.5%, CREE +3.3%, AMD +3%, MT +2.7%, ANF +2.3%, MOMO +2.2%, GM +2.1%, SQ +2.1%, JD +2%, BABA +1.9%, KSU +1.7%, JPM +1.7%, BHP +1.6%, BBL +1.5%, F +1.4%, WB +1.4%, BBVA +1.3%, BIDU +1.1%, MU +1.1%, BAC +1.1%, SAN +1.1%, WFC +0.8%

Gapping down:

  • ONCE -14.9%, DRD -4.5%, CRK -3.6%, CRM -3.2%, SBGL -3.2%, GPRO -2.9%, AG -2.8%, GOLD -2.4%, GFI -2.4%, AU -2.3%, RIO -1.9%, STM -1.9%, SLV -1.7%, GDX -1.7%, HMY -1.6%, SAND -1.3%, GLD -1.1%

FT : Neil Woodford blocks customers from seeing full list of investments Fund ma

Neil Woodford blocks customers from seeing full list of investments
Fund manager had previously taken unusual step of publishing complete holdings

Neil Woodford has blocked investors from seeing the complete holdings in his three main funds as he drastically readjusts his portfolios to meet redemption requests.

Mr Woodford launched his investment management business five years ago with the promise to be as open with customers as possible. This included taking the unusual step of publishing the complete list of holdings in his three main funds, Equity Income, Income Focus and Patient Capital Trust.

Fund managers typically publish a short list of their holdings, such as the 10 largest stocks, saying providing full disclosure could invite other investors to mimic their strategies.

But the dramatic decision by Mr Woodford’s investment business to suspend dealing in his £3.7bn equity income fund has prompted a change in stance.

“During the period of the LF Woodford Equity Income fund’s suspension and subsequent repositioning of its portfolio, we will only be showing the top 10 holdings of our three funds. We firmly believe this is in the best interests of investors,” said Woodford Investment Management in a statement.

Trading in the equity income fund has been suspended for at least 28 days while Mr Woodford is able to sell enough assets to meet redemption requests and reduce the fund’s exposure to unlisted stocks.

The fund manager continues to receive a fee for running the fund, despite heavy criticism from politicians over doing so throughout its suspension.